Adjuvant Therapy [topp]    
HEPATOCELLULAR CARCINOMA [neop]    
Administering [topp]    
mg/d [qnco]    
promise [idcn]    
Reducing [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
YEAR [tmco]    
Following [tmco]    
Curative [cnce]    
resection [topp]    
Methods [inpr]    
Patients [podg]    
participants [popg]    
Phase [tmco]    
Study [mnob]    
Study, Followup [resa]    
Patients [podg]    
RECEIVED [qlco]    
treatment [ftcn]    
RECEIVED [qlco]    
mg/d [qnco]    
RECEIVED [qlco]    
mg/d [qnco]    
Phase [tmco]    
Trial [resa]    
Safety [hcpp]    
Parameters [fndg]    
Following [tmco]    
Efficacy [qlco]    
endpoints [qlco]    
investigated [ftcn]    
TIME [tmco]    
Disease-Free Survival [qnco]    
Survival [acty]    
mg/d [qnco]    
Delayed [tmco]    
Onset [qnco]    
Frequency [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
Provided [acty]    
Survival [acty]    
YEARS [tmco]    
treatment [ftcn]    
Compared [acty]    
Control Group [grup]    
free [ftcn]    
Increased [qnco]    
TIME [tmco]    
Percentile [qnco]    
Efficacy [qlco]    
Administering [topp]    
mg/d [qnco]    
dropout [popg]    
Patients [podg]    
Subgroup Analysis [resa]    
Patients [podg]    
Multiple tumors [neop]    
Single tumour [neop]    
HEPATITIS B [dsyn]    
Revealed [qlco]    
Administering [topp]    
mg/d [qnco]    
Most significant [qlco]    
Survival [acty]    
Improvement [cnce]    
Disease-Free Survival [qnco]    
Patients [podg]    
Risk Factors [qnco]    
Administering [topp]    
mg/d [qnco]    
Well [qlco]    
Dosage [qnco]    
Benefits [qnco]    
Patients [podg]    
HEPATOCELLULAR CARCINOMA [neop]    
Publishing [ocac]    
Group [idcn]    
rights [qlco]    
Reserve [acty]    
